Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine-Reference-Cited by-同舟云学术

Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine

Published:2014-06-19 Issue:8 Volume:10 Page:2147-2162
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Naud Paulo S,Roteli-Martins Cecilia M,De Carvalho Newton S,Teixeira Julio C,de Borba Paola C,Sanchez Nervo,Zahaf Toufik,Catteau Gregory,Geeraerts Brecht,Descamps Dominique

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/hv.29532

Reference34 articles.

1. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

2. The causal relation between human papillomavirus and cervical cancer

3. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

4. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

5. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How has post-implementation surveillance of high-coverage vaccination with HPV16/18-AS04 vaccine in England added to evidence about its cross-protective effects?;Vaccine;2024-10

2. Comparative Analysis of HPV16 Variants in the Untranslated Regulatory Region, L1, and E6 Genes among Vaccinated and Unvaccinated Young Women: Assessing Vaccine Efficacy and Viral Diversity;Viruses;2024-08-29

3. Adjuvants for Antigens in Vaccines: Review;Research Journal of Pharmacy and Technology;2024-07-24

4. A Systematic Review of Human Papillomavirus Vaccination Challenges and Strategies to Enhance Uptake;Vaccines;2024-07-06

5. Vaccination and screening strategies to accelerate cervical cancer elimination in Norway: a model-based analysis;British Journal of Cancer;2024-04-20